In the afternoon of July 22, the American Cancer Society instructed the staff of its National Home Office to pick up their belongings and equipment before July 30.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
